← Back to Clinical Trials
Recruiting NCT07366164

NCT07366164 Hemodynamic Optimization Using an Artificial Intelligenze System

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07366164
Status Recruiting
Phase
Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Condition Hemodynamic (MAP) Stability
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2025-10-01
Primary Completion 2026-06-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
assisted fluid therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2025-10-01 with a primary completion date of 2026-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will investigate the impact of using an automated fluid management system on intraoperative fluid therapy in patients undergoing colorectal surgery. The aim is to evaluate whether automated guidance can optimize hemodynamic stability and reduce the incidence of arterial hypotension,

Eligibility Criteria

Inclusion Criteria: \- patients \>18 years old and ASA 3 scheduled for laparoscopic colorectal surgery Exclusion Criteria: * Refusal of consent * Body Mass Index \> 35 kg/m2 * urgent cases * pregnancy

Contact & Investigator

Central Contact

andrea russo, medical doctor

✉ russoandreamd@gmail.com

📞 +393333926815

Principal Investigator

andrea russo

PRINCIPAL INVESTIGATOR

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Frequently Asked Questions

Who can join the NCT07366164 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Hemodynamic (MAP) Stability. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07366164 currently recruiting?

Yes, NCT07366164 is actively recruiting participants. Contact the research team at russoandreamd@gmail.com for enrollment information.

Where is the NCT07366164 trial being conducted?

This trial is being conducted at Roma, Italy.

Who is sponsoring the NCT07366164 clinical trial?

NCT07366164 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The principal investigator is andrea russo at Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology